Now showing items 1-2 of 2
Polymeric delivery of inhibitors of smooth muscle cell proliferation
Restenosis, currently estimated to occur in 30-50% of dilated lesions, continues to be a major limitation to the success of current interventional cardiovascular procedures. Presently, no established therapy prevents or ...
Injectable, in situ polymerizable, biodegradable scaffolds based on poly(propylene fumarate) for guided bone regeneration
Poly(propylene fumarate) (PPF) was developed as a scaffold to guide bone regeneration. Synthesis of this material via refined reaction pathways led to increased purity and higher molecular weights of this unsaturated, ...